Menu

News Alert

Federal Judge Denies Drugmakers’ Bid to Block Rhode Island’s 340B Contract Pharmacy Access Law

William Newton, Associate Editor/Senior Writer 340B Report Views
Chief Judge John McConnell Jr. of the U.S. District Court for the District of Rhode Island denied AbbVie and Novartis’ motions for preliminary injunction against Rhode Island’s contract pharmacy access law.
A federal district judge today denied two drugmakers’ attempts to block Rhode Island’s 340B contract pharmacy access law, clearing the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Kansas Special Legislative Hearing on 340B Gives Platform to Drug Industry-Aligned Groups

William Newton, Associate Editor/Senior Writer 340B Report Views
The Kansas Legislature convened a Sept. 26 all-day special committee hearing that focused on the 340B drug pricing program.
Kansas state legislators last Friday held an all-day special hearing on the 340B program that tilted heavily toward drug industry-aligned [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

PhRMA, Drugmakers Look to Comply with Parts of ‘Most Favored Nation’ EO, Call on Congress to Address 340B, PBMs

Shannon Young, Associate Editor/Senior Writer 340B Report Views
PhRMA President and CEO Stephen Ubl touts the drug industry's efforts to comply with Trump administration drug pricing initiatives in a recent video posted on Americasmedicines.com.
An influential drug industry trade group said Monday it will launch a new direct-to-consumer sales website as part of an [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Industry Insights Logo

A Coming Storm—or Opportunity: How the 340B Rebate Pilot and Medicare MFP Could Strain or Strengthen the Drug Supply Chain

Sponsored Content 340B Report Views
Learn More about a Platform Built for This Challenge

SPONSORED CONTENT

The U.S. drug pricing infrastructure is entering a transformative era. On August 1, 2025, the Health Resources and Services Administration (HRSA) announced a voluntary 340B Rebate Model Pilot, aligned with the Inflation Reduction Act’s Maximum Fair Price (MFP) provisions

…
Read More »

Trump to Impose Tariffs Oct. 1 on Drugmakers Not Scaling Up U.S. Manufacturing

Shannon Young, Associate Editor/Senior Writer 340B Report Views
President Donald Trump announced that the new pharmaceutical tariffs will take effect Oct. 1 in a Sept. 25 Truth Social post.
Drugmakers that are not building a pharmaceutical manufacturing plant in the U.S. will soon face “a 100% tariff on any [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Ten GOP Governors Ask HRSA to Remove Planned Parenthood from 340B

William Newton, Associate Editor/Senior Writer 340B Report Views
The Republican governors of 10 U.S. states signed a letter urging HRSA to revoke Planned Parenthood's 340B eligibility.
Ten Republican state governors recently urged the Health Resources and Services Administration (HRSA) to revoke Planned Parenthood’s eligibility for the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Column: A Deep Dive into CBO’s New 340B Report and Why It Significantly Misses the Mark

Ted Slafsky, Publisher & CEO 340B Report Views
Ted Slafsky, publisher and CEO of 340B Report, examines the CBO's recent report on the 340B drug discount program.
The respected, nonpartisan Congressional Budget Office (CBO) doesn’t often study the 340B drug discount program; therefore stakeholders need to take [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Michigan House Panel Hears Testimony on 340B Bill as Key GOP Leader, Dark Money Group Step Up Attacks on Hospitals

William Newton, Associate Editor/Senior Writer 340B Report Views
The Michigan House Health Policy Committee held a Sept. 24 hearing on a 340B bill with contract pharmacy and reporting provisions.
A Michigan House committee heard testimony yesterday on a 340B contract pharmacy access bill with hospital and drugmaker reporting requirements, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Several Drugmakers Exempt New States from 340B Contract Pharmacy Restrictions

Shannon Young, Associate Editor/Senior Writer 340B Report Views
AbbVie, Alkermes, Biogen, Liquidia and Merck recently announced new state 340B contract pharmacy restriction exemptions.
Five drugmakers are exempting additional states from their 340B contract pharmacy restrictions due to new contract pharmacy access laws they’ve [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Industry Insights Logo

Resolving Negative Accumulations in a Virtual Inventory: What Would You Do?

Sponsored Content 340B Report Views
Explore potential next steps for resolution

SPONSORED CONTENT

Consider the following scenario: A recent change in electronic health record billing at one of your outpatient clinics has led to accumulation errors in your 340B split-billing software, resulting in overpurchasing of 340B drugs. Although hypothetical, this scenario illustrates just one of many inventory-related situations

…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live